Bill Information > HB 2363
Search for another bill or initiative:
HB 2363 - 2015-16
Concerning pharmaceutical drug cost and utilization transparency.
Bill History
2016 REGULAR SESSION
IN THE HOUSE
Jan 8
Prefiled for introduction.
Jan 11
First reading, referred to Health Care & Wellness (Not Officially read and referred until adoption of Introduction report).
(View Original Bill)
Jan 19
Public hearing in the House Committee on Health Care & Wellness at 8:00 AM.
(Committee Materials)
Jan 27
Executive session scheduled, but no action was taken in the House Committee on Health Care & Wellness at 1:30 PM.
(Committee Materials)
Jan 29
Executive session scheduled, but no action was taken in the House Committee on Health Care & Wellness at 10:00 AM.
(Committee Materials)
2016 1ST SPECIAL SESSION
IN THE HOUSE
Mar 10
By resolution, reintroduced and retained in present status.
Available Documents
For a complete list of documents, go to Online Reports Text of a Legislative Document.

Fiscal Note
Amendments

Available Videos
